{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T14:20:03Z","timestamp":1792851603688,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T00:00:00Z","timestamp":1666656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T00:00:00Z","timestamp":1666656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004085","name":"Ministry of Education, Science and Technology","doi-asserted-by":"publisher","award":["NRF-2020R1A2C3007378"],"award-info":[{"award-number":["NRF-2020R1A2C3007378"]}],"id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004085","name":"Ministry of Education, Science and Technology","doi-asserted-by":"publisher","award":["NRF-2021M3E5E5096464"],"award-info":[{"award-number":["NRF-2021M3E5E5096464"]}],"id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004085","name":"Ministry of Education, Science and Technology","doi-asserted-by":"publisher","award":["2022R1A6A1A03053343"],"award-info":[{"award-number":["2022R1A6A1A03053343"]}],"id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Neurodegener"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The \u03b54 allele of apolipoprotein E (<jats:italic>APOE<\/jats:italic> \u03b54) is the strongest known genetic risk factor for late-onset Alzheimer\u2019s disease (AD), associated with amyloid pathogenesis. However, it is not clear how <jats:italic>APOE<\/jats:italic> \u03b54 accelerates amyloid-beta\u00a0(A\u03b2) deposition during the seeding stage of amyloid development in AD patient neurons.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>AD patient induced neurons (iNs) with an <jats:italic>APOE<\/jats:italic> \u03b54 inducible system were prepared from skin fibroblasts of AD patients. Transcriptome analysis was performed using RNA isolated from the AD patient iNs expressing <jats:italic>APOE<\/jats:italic> \u03b54 at amyloid-seeding and amyloid-aggregation stages. Knockdown of IGFBP3 was applied in the iNs to investigate the role of IGFBP3 in the <jats:italic>APOE<\/jats:italic> \u03b54-mediated amyloidosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We optimized amyloid seeding stage in the iNs of AD patients that transiently expressed <jats:italic>APOE<\/jats:italic> \u03b54. Remarkably, we demonstrated that A\u03b2\u00a0 pathology was aggravated by the induction of <jats:italic>APOE<\/jats:italic> \u03b54 gene expression at the amyloid early-seeding stage in the iNs of AD patients. Moreover, transcriptome analysis in the early-seeding stage revealed that IGFBP3 was functionally important in the molecular pathology of <jats:italic>APOE<\/jats:italic> \u03b54-associated AD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our findings suggest that the presence of <jats:italic>APOE<\/jats:italic> \u03b54 at the early A\u03b2-seeding stage in patient iNs is critical for aggravation of sporadic AD pathology. These results provide insights into the importance of <jats:italic>APOE<\/jats:italic> \u03b54 expression for the progression and pathogenesis of sporadic AD.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40035-022-00319-9","type":"journal-article","created":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T10:03:15Z","timestamp":1666692195000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["APOE \u03b54-dependent effects on the early amyloid pathology in induced neurons\u00a0of patients with Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"11","author":[{"given":"Hongwon","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byounggook","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaein","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3876-6020","authenticated-orcid":false,"given":"Jongpil","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,25]]},"reference":[{"issue":"10","key":"319_CR1","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1172\/JCI0216783","volume":"110","author":"DJ Selkoe","year":"2002","unstructured":"Selkoe DJ. Deciphering the genesis and fate of amyloid beta-protein yields novel therapies for Alzheimer disease. J Clinical Invest. 2002;110(10):1375\u201381.","journal-title":"J Clinical Invest"},{"issue":"4","key":"319_CR2","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1002\/ana.22615","volume":"70","author":"M Jucker","year":"2011","unstructured":"Jucker M, Walker LC. Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders. Ann Neurol. 2011;70(4):532\u201340.","journal-title":"Ann Neurol"},{"issue":"2","key":"319_CR3","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1001\/archneur.62.2.192","volume":"62","author":"DJ Selkoe","year":"2005","unstructured":"Selkoe DJ. Defining molecular targets to prevent Alzheimer disease. Arch Neurol. 2005;62(2):192\u20135.","journal-title":"Arch Neurol"},{"issue":"7673","key":"319_CR4","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nature24016","volume":"549","author":"Y Shi","year":"2017","unstructured":"Shi Y, Yamada K, Liddelow SA, Smith ST, Zhao L, Luo W, et al. ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy. Nature. 2017;549(7673):523\u20137.","journal-title":"Nature"},{"issue":"9","key":"319_CR5","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1202753","volume":"367","author":"RJ Bateman","year":"2012","unstructured":"Bateman RJ, Xiong C, Benzinger TL, Fagan AM, Goate A, Fox NC, et al. Clinical and biomarker changes in dominantly inherited Alzheimer\u2019s disease. N Engl J Med. 2012;367(9):795\u2013804.","journal-title":"N Engl J Med"},{"issue":"7266","key":"319_CR6","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/nature08538","volume":"461","author":"RJ Perrin","year":"2009","unstructured":"Perrin RJ, Fagan AM, Holtzman DM. Multimodal techniques for diagnosis and prognosis of Alzheimer\u2019s disease. Nature. 2009;461(7266):916\u201322.","journal-title":"Nature"},{"issue":"1","key":"319_CR7","doi-asserted-by":"publisher","first-page":"32","DOI":"10.2174\/1567205012666141218140953","volume":"12","author":"RJ Baranello","year":"2015","unstructured":"Baranello RJ, Bharani KL, Padmaraju V, Chopra N, Lahiri DK, Greig NH, et al. Amyloid-beta protein clearance and degradation (ABCD) pathways and their role in Alzheimer\u2019s disease. Curr Alzheimer Res. 2015;12(1):32\u201346.","journal-title":"Curr Alzheimer Res"},{"issue":"12","key":"319_CR8","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1056\/NEJM199603213341202","volume":"334","author":"EM Reiman","year":"1996","unstructured":"Reiman EM, Caselli RJ, Yun LS, Chen K, Bandy D, Minoshima S, et al. Preclinical evidence of Alzheimer\u2019s disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Engl J Med. 1996;334(12):752\u20138.","journal-title":"N Engl J Med"},{"issue":"Pt 11","key":"319_CR9","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1093\/brain\/awh595","volume":"128","author":"GM Teasdale","year":"2005","unstructured":"Teasdale GM, Murray GD, Nicoll JA. The association between APOE epsilon4, age and outcome after head injury: a prospective cohort study. Brain. 2005;128(Pt 11):2556\u201361.","journal-title":"Brain"},{"issue":"89","key":"319_CR10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1126\/scitranslmed.3002156","volume":"3","author":"JM Castellano","year":"2011","unstructured":"Castellano JM, Kim J, Stewart FR, Jiang H, DeMattos RB, Patterson BW, et al. Human apoE isoforms differentially regulate brain amyloid-\u03b2 peptide clearance. Sci Transl Med. 2011;3(89):57.","journal-title":"Sci Transl Med"},{"issue":"1","key":"319_CR11","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13024-017-0156-1","volume":"12","author":"JE Pankiewicz","year":"2017","unstructured":"Pankiewicz JE, Baquero-Buitrago J, Sanchez S, Lopez-Contreras J, Kim J, Sullivan PM, et al. APOE genotype differentially modulates effects of anti-A\u03b2, passive immunization in APP transgenic mice. Mol Neurodegeneration. 2017;12(1):12.","journal-title":"Mol Neurodegeneration"},{"issue":"5","key":"319_CR12","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.neuron.2017.11.013","volume":"96","author":"CC Liu","year":"2017","unstructured":"Liu CC, Zhao N, Fu Y, Wang N, Linares C, Tsai CW, et al. ApoE4 accelerates early seeding of amyloid pathology. Neuron. 2017;96(5):1024-1032.e1023.","journal-title":"Neuron"},{"issue":"5","key":"319_CR13","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.neuron.2017.11.014","volume":"96","author":"TV Huynh","year":"2017","unstructured":"Huynh TV, Liao F, Francis CM, Robinson GO, Serrano JR, Jiang H, et al. Age-dependent effects of apoe reduction using antisense oligonucleotides in a model of \u03b2-amyloidosis. Neuron. 2017;96(5):1013-1023.e1014.","journal-title":"Neuron"},{"key":"319_CR14","first-page":"4383","volume":"10","author":"SY Choi","year":"2015","unstructured":"Choi SY, Song MS, Ryu PD, Lam ATN, Joo S-W, Lee SY. Gold nanoparticles promote osteogenic differentiation in human adipose-derived mesenchymal stem cells through the Wnt\/\u03b2-catenin signaling pathway. Int J Nanomedicine. 2015;10:4383.","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"319_CR15","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.stem.2020.08.015","volume":"28","author":"K Cates","year":"2021","unstructured":"Cates K, McCoy MJ, Kwon JS, Liu Y, Abernathy DG, Zhang B, et al. Deconstructing stepwise fate conversion of human fibroblasts to neurons by microRNAs. Cell Stem Cell. 2021;28(1):127-140.e129.","journal-title":"Cell Stem Cell"},{"issue":"7359","key":"319_CR16","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nature10202","volume":"476","author":"ZP Pang","year":"2011","unstructured":"Pang ZP, Yang N, Vierbuchen T, Ostermeier A, Fuentes DR, Yang TQ, et al. Induction of human neuronal cells by defined transcription factors. Nature. 2011;476(7359):220\u20133.","journal-title":"Nature"},{"issue":"1","key":"319_CR17","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/jnr.24615","volume":"99","author":"GX D'Souza","year":"2021","unstructured":"D\u2019Souza GX, Rose SE, Knupp A, Nicholson DA, Keene CD, Young JE. The application of in vitro-derived human neurons in neurodegenerative disease modeling. J Neurosci Res. 2021;99(1):124\u201340.","journal-title":"J Neurosci Res"},{"issue":"8","key":"319_CR18","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1093\/brain\/awx144","volume":"140","author":"H Kim","year":"2017","unstructured":"Kim H, Yoo J, Shin J, Chang Y, Jung J, Jo DG, et al. Modelling APOE \u025b3\/4 allele-associated sporadic Alzheimer\u2019s disease in an induced neuron. Brain. 2017;140(8):2193\u2013209.","journal-title":"Brain"},{"issue":"9","key":"319_CR19","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1016\/j.stem.2021.04.004","volume":"28","author":"J Mertens","year":"2021","unstructured":"Mertens J, Herdy JR, Traxler L, Schafer ST, Schlachetzki JCM, B\u00f6hnke L, et al. Age-dependent instability of mature neuronal fate in induced neurons from Alzheimer\u2019s patients. Cell Stem Cell. 2021;28(9):1533-1548.e1536.","journal-title":"Cell Stem Cell"},{"issue":"3","key":"319_CR20","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.stemcr.2019.01.020","volume":"12","author":"H Kim","year":"2019","unstructured":"Kim H, Park HJ, Choi H, Chang Y, Park H, Shin J, et al. Modeling G2019S-LRRK2 sporadic Parkinson\u2019s disease in 3D midbrain organoids. Stem Cell Reports. 2019;12(3):518\u201331.","journal-title":"Stem Cell Reports"},{"issue":"4","key":"319_CR21","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41593-019-0352-0","volume":"22","author":"H Park","year":"2019","unstructured":"Park H, Oh J, Shim G, Cho B, Chang Y, Kim S, et al. In vivo neuronal gene editing via CRISPR-Cas9 amphiphilic nanocomplexes alleviates deficits in mouse models of Alzheimer\u2019s disease. Nature Neuroscie. 2019;22(4):524\u20138.","journal-title":"Nature Neuroscie"},{"key":"319_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.709091","volume":"13","author":"H Kim","year":"2021","unstructured":"Kim H, Kim S, Park SJ, Park G, Shin H, Park MS, et al. Administration of bifidobacterium bifidum BGN4 and bifidobacterium longum BORI improves cognitive and memory function in the mouse model of Alzheimer\u2019s disease. Front Aging Neurosci. 2021;13: 709091.","journal-title":"Front Aging Neurosci"},{"issue":"43","key":"319_CR23","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"319_CR24","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/0006-8993(91)91092-F","volume":"541","author":"Y Namba","year":"1991","unstructured":"Namba Y, Tomonaga M, Kawasaki H, Otomo E, Ikeda K. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer\u2019s disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res. 1991;541(1):163\u20136.","journal-title":"Brain Res"},{"issue":"5","key":"319_CR25","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/s41591-018-0004-z","volume":"24","author":"C Wang","year":"2018","unstructured":"Wang C, Najm R, Xu Q, Jeong DE, Walker D, Balestra ME, et al. Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector. Nat Med. 2018;24(5):647\u201357.","journal-title":"Nat Med"},{"issue":"1","key":"319_CR26","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13024-022-00516-0","volume":"17","author":"TE Mahan","year":"2022","unstructured":"Mahan TE, Wang C, Bao X, Choudhury A, Ulrich JD, Holtzman DM. Selective reduction of astrocyte apoE3 and apoE4 strongly reduces A\u03b2 accumulation and plaque-related pathology in a mouse model of amyloidosis. Mol Neurodegen. 2022;17(1):13.","journal-title":"Mol Neurodegen"},{"issue":"9","key":"319_CR27","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1016\/j.stemcr.2021.07.017","volume":"16","author":"SI Lee","year":"2021","unstructured":"Lee SI, Jeong W, Lim H, Cho S, Lee H, Jang Y, et al. APOE4-carrying human astrocytes oversupply cholesterol to promote neuronal lipid raft expansion and A\u03b2 generation. Stem Cell Reports. 2021;16(9):2128\u201337.","journal-title":"Stem Cell Reports"},{"key":"319_CR28","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awab478","author":"RJ Jackson","year":"2021","unstructured":"Jackson RJ, Meltzer JC, Nguyen H, Commins C, Bennett RE, Hudry E, et al. APOE4 derived from astrocytes leads to blood-brain barrier impairment. Brain. 2021. https:\/\/doi.org\/10.1093\/brain\/awab478.","journal-title":"Brain"},{"issue":"7","key":"319_CR29","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, et al. A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell. 2017;169(7):1276-1290.e1217.","journal-title":"Cell"},{"issue":"7","key":"319_CR30","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1002\/alz.12287","volume":"17","author":"AJ Griswold","year":"2021","unstructured":"Griswold AJ, Celis K, Bussies PL, Rajabli F, Whitehead PL, Hamilton-Nelson KL, et al. Increased APOE \u03b54 expression is associated with the difference in Alzheimer\u2019s disease risk from diverse ancestral backgrounds. Alzheimers Dement. 2021;17(7):1179\u201388.","journal-title":"Alzheimers Dement"},{"issue":"19","key":"319_CR31","doi-asserted-by":"publisher","first-page":"4985","DOI":"10.1523\/JNEUROSCI.5476-05.2006","volume":"26","author":"Q Xu","year":"2006","unstructured":"Xu Q, Bernardo A, Walker D, Kanegawa T, Mahley RW, Huang Y. Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus. J Neurosci. 2006;26(19):4985\u201394.","journal-title":"J Neurosci"},{"issue":"3","key":"319_CR32","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1172\/JCI124853","volume":"129","author":"M Tachibana","year":"2019","unstructured":"Tachibana M, Holm ML, Liu CC, Shinohara M, Aikawa T, Oue H, et al. APOE4-mediated amyloid-\u03b2 pathology depends on its neuronal receptor LRP1. J Clinical Invest. 2019;129(3):1272\u20137.","journal-title":"J Clinical Invest"},{"issue":"7","key":"319_CR33","doi-asserted-by":"publisher","first-page":"4539","DOI":"10.1007\/s12035-015-9388-7","volume":"53","author":"Y Liu","year":"2016","unstructured":"Liu Y, Tan L, Wang HF, Liu Y, Hao XK, Tan CC, et al. Multiple effect of APOE genotype on clinical and neuroimaging biomarkers across Alzheimer\u2019s disease spectrum. Mol Neurobiol. 2016;53(7):4539\u201347.","journal-title":"Mol Neurobiol"},{"issue":"5","key":"319_CR34","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nrn2620","volume":"10","author":"G Bu","year":"2009","unstructured":"Bu G. Apolipoprotein E and its receptors in Alzheimer\u2019s disease: pathways, pathogenesis and therapy. Nat Rev Neurosci. 2009;10(5):333\u201344.","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"319_CR35","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13041-015-0174-2","volume":"8","author":"K Watanabe","year":"2015","unstructured":"Watanabe K, Uemura K, Asada M, Maesako M, Akiyama H, Shimohama S, et al. The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer\u2019s disease. Mol Brain. 2015;8(1):82.","journal-title":"Mol Brain"}],"container-title":["Translational Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-022-00319-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40035-022-00319-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-022-00319-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T22:05:16Z","timestamp":1666735516000},"score":1,"resource":{"primary":{"URL":"https:\/\/translationalneurodegeneration.biomedcentral.com\/articles\/10.1186\/s40035-022-00319-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,25]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["319"],"URL":"https:\/\/doi.org\/10.1186\/s40035-022-00319-9","relation":{},"ISSN":["2047-9158"],"issn-type":[{"value":"2047-9158","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,25]]},"assertion":[{"value":"12 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"45"}}